SCHEMBL4599507

SCHEMBL4599507

NC1=CC(OCc2ccccc2)=CC[CH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
MAPT P10636 2/20 0.44
MAOA P21397 2/20 0.44
GAA P10253 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LTA4H P09960 1/20 0.40
MAPK14 Q16539 1/20 0.40
IDO1 P14902 1/20 0.39
AGXT P21549 1/20 0.38
NSD2 O96028 1/20 0.38
ABL1 P00519 1/20 0.38
PPARG P37231 1/20 0.38
RIN1 Q13671 1/20 0.38
NCOR2 Q9Y618 1/20 0.38
HTT P42858 1/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
PTGS1 P23219 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16151278 0.79 CYP1A2 (0.46) MAOBL3MBTL1MAPTMAOAGAA
SCHEMBL12180839 0.71 L3MBTL1 (0.43) MAOBL3MBTL1MAPTMAOAGAA
SCHEMBL5570979 0.69 LMNA (0.42) MAOBL3MBTL1MAPTMAOAGAA
SCHEMBL1557213 0.68 TSHR (0.40) MAOBL3MBTL1MAPTMAOAGAA
SCHEMBL19411249 0.68 LMNA (0.44) MAOBL3MBTL1MAPTMAOAGAA
SCHEMBL7694567 0.67 LMNA (0.39) MAOBL3MBTL1MAPTMAOAGAA
SCHEMBL7525635 0.64 MAOB (0.43) MAOBL3MBTL1MAPTMAOAGAA
SCHEMBL1755623 0.64 TSHR (0.40) MAOBL3MBTL1MAPTMAOAGAA
SCHEMBL5601610 0.64 TSHR (0.40) MAOBL3MBTL1MAPTMAOAGAA
SCHEMBL8316680 0.63 MAOB (0.55) MAOBL3MBTL1MAPTMAOAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP claimed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO claimed
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed